WEDNESDAY, Aug. 15, 2018 — For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an
Continue reading »
Pfizer says not part of failed Dutch pregnancy trial
Pfizer Thursday insisted its anti-impotency Viagra drug was not used in a Dutch study seeking to help pregnant women whose
Continue reading »BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia
AIRPORT CITY, Israel, July 11, 2018 /PRNewswire/ — BioSight Ltd., a pharmaceutical development company focused on the development of targeted
Continue reading »Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of Pixuvri (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
SEATTLE, July 9, 2018 /PRNewswire/ — CTI BioPharma Corp. (NASDAQ:CTIC) and Servier today announced that the pivotal Phase III trial
Continue reading »Promising clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer
Phase 1b clinical trial results published in JAMA Oncology show promise for the combination of tucatinib (formerly ONT-380) with T-DM1
Continue reading »A commonly offered add-on treatment for IVF fails to provide any benefit in a large randomized trial
An add-on treatment commonly offered to female IVF patients to improve their chance of success has been shown in a
Continue reading »New clinical trial takes personalized approach for rare type of ALS in Appalachia
ALS, or amyotrophic lateral sclerosis, is a neurodegenerative disease of some fame in the United States. Many Americans know the
Continue reading »ALEX trial results show alectinib further outpacing crizotinib in ALK+ NSCLC
Updated results of the global phase III ALEX trial comparing alectinib with crizotinib as first-line treatment against ALK-positive non-small cell
Continue reading »Trial shows how PET scans help tailor therapy for esophageal cancer
Survival results for the CALGB 80303 Trial presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018
Continue reading »NIH begins testing Ebola treatment in early-stage trial
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH)
Continue reading »